Chatzinikolaou PN, Margaritelis NV, Paschalis V, Theodorou AA, Vrabas IS, Kyparos A, et al
It operates through a dual-action mechanism that targets two important hormones in the body: GLP-1 and GIP
Not everyone experiences them, and their severity can varybut they are among the concerns many people want to understand before beginning treatment
People with chronic kidney disease (CKD) , diabetes, or hypertension should discuss weight loss medication options carefully with their GP or specialist, as some treatments may require dose adjustments or additional monitoring
Multivariate Prediction Equations for HbA(1c) Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling
15.0% 5 mg dose mean loss Mean body weight loss on the 5 mg maintenance dose at 72 weeks vs 3.1% placebo